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Objective. To determine the safety and the long-term results of primary stent placement for localized distal aortic occlusive
disease.
Design. Retrospective observational study.
Patients and Methods. From July 1998 to July 2005 17 patients (14 female and 3 men, mean age 57 years (39e80)) were
treated for intermittent claudication. Five of these patients underwent additional endovascular treatment of focal iliac lesions.
Results. Technical success defined as residual stenosis of less than 50% or a trans-stenotic systolic pressure gradient
<10% was achieved in 14 of 17 (82%) patients. Major complications included dissection at the puncture site in one patient
and thrombosis of additional iliac stents in another patient. Both of these complications were successfully treated. During
a mean follow-up of 27 months (range 1e86), four patients had recurrence of symptoms due to in-stent restenoses (n¼ 2),
femoral (n¼ 1) or iliac occlusion (n¼ 1), respectively. By Kaplan-Meier analysis, primary aortic hemodynamic patency
was 83% at 3 years. Secondary aortic hemodynamic patency was 100%. The primary clinical patency was 68% at 3 years.
Conclusion. Primary stent placement for distal aortic stenoses is an alternative to surgical treatment because of its high
patency and relatively low complication rates.
Keywords: Abdominal aorta; Aortic occlusive disease; Endovascular stenting.Introduction
Focal stenosis of the infrarenal aorta is relatively rare
and occurs predominantly in young women who are
heavy smokers and have elevated lipid levels.1 Aortic
endarterectomy and aortic bypass surgery have been
traditional treatment options for these lesions. The
long-term results of surgery show excellent patency
rates, however, surgery is associated with significant
mortality and morbidity rates.2e5 Moreover, in male
patients surgical procedures may lead to sexual
dysfunction.
Since the 1980s percutaneous transluminal angio-
plasty (PTA) has been used to treat focal stenosis of
the abdominal aorta with encouraging short-term
and long-term results.6e16 PTA is less invasive than
surgery with less complications and lower costs. Stent
implantation may be an efficacious option when PTA
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data on the primary use of stents for treatment of in-
frarenal aortic stenoses.27e32
The objectives of this study were to evaluate the
safety, long-term clinical results and patency rates of
primary stent placement for stenosis of the infrarenal
aorta.
Patients and Methods
Institutional ethical approval was not required for this
study. Seventeen consecutive patients (14 female and
three men) with a mean age of 57 (range 39e80) years
underwent primary stent placement for focal infrare-
nal aortic stenosis between July 1998 and July 2005
in two community hospitals, one being a teaching
hospital. During the same period no patients were
treated surgically for distal aortic stenosis. Patients
with involvement of the aortic bifurcation and iliac
arteries requiring kissing stents were excluded from
this study. Patients’ characteristics are presented in
Table 1. All patients presented with moderate orerved.
628 P. C. G. Simons et al.severe intermittent claudication (category 2 and 3 ac-
cording to the classification of the Society of Vascular
Surgery and International Society for Cardiovascular
Surgery (SVS/ISCVS))33 and had hemodynamically
significant stenosis (>50%) of the infrarenal aorta on
color Doppler ultrasound (CDU). All aortic stenoses
were caused by obliterating atherosclerosis.
For stent placement a retrograde femoral approach
was used under local anesthesia. After placement of
an 8 Fr sheath and administration of 5000 IU of heparin
intra-arterially, the aortic lesionswere transversedwith
a 0.035 inch hydrophilic guidewire (Terumo, Tokyo,
Japan) over which a 5F diagnostic catheter was placed
in the abdominal aorta followed by diagnostic digital
subtraction angiography of the aorto-iliac tract. Lesion
length and types are listed in Table 1. Sixteen patients
had a stenosis of the distal aorta and one patient had
an occlusion with a length of 2 cm. After pre-dilation
of the aortic lesion with an undersized balloon with
a diameter of 6e8 mm, a self-expandable nitinol stent
(Smart stent, Cordis Johnson and Johnson, Roden,
The Netherlands) was placed in 10 patients, and a
balloon-expandable stainless steel stent (Palmaz stent
Table 1. Characteristics of 17 patients undergoing primary aortic
stent placement
Characteristic Mean (range) Number
Age (years) 57 (39e80)
Sex
Females 14
Males 3
Risk factors
Smoking 14
Hyperlipidemia 13
Diabetes 2
Hypertension 6
Cardiac disease 5
Cerebral vascular disease 2
Pre-treatment ankle brachial index
Right 0.72 (0.40e0.94)
Left 0.78 (0.53e1.10)
Length of lesion
<2 cm 9
2e4 cm 6
>4 cm 2
Lesion type
Concentric 9
Eccentric 5
Ulceration 2
Occlusion 1
Additional procedures
PTA right CIA 1
Stent left CIA 1
Stent both CIA 2
Stent right CIA, PTA left CIA 1
Femoropopliteal bypass 1
PTA¼ Percutaneous Transluminal Angioplasty.
CIA¼Common Iliac Artery.Eur J Vasc Endovasc Surg Vol 32, December 2006n¼ 6 and a Genesis stent n¼ 1, Cordis Johnson and
Johnson, Roden, The Netherlands) in 7 patients
(Fig. 1). There were no strict guidelines for stent selec-
tion which was left to the personal choice of the inter-
ventional radiologist. The stents had diameters of
9e14 mm and lengths of 20e60 mm. After stent place-
ment the self-expandable stents were post-dilated with
a 12e14 mm Opta balloon (Cordis Johnson and John-
son, Roden, The Netherlands). Systolic pressure gradi-
ents were measured across the aortic lesion after stent
placement and a control angiogram was performed.
Eight patients had an isolated aortic lesion and 9
patients had multi-level disease. In five of these nine
patients the aortic intervention was combined with
PTA or stenting of stenoses in the iliac arteries and in
one patient a femoropopliteal bypass was performed
shortly after the aortic stent placement (Table 1).
Antiplatelet agents (aspirin 100 mg/day) were con-
tinued routinely after the procedure. Patients were
also advised to quit smoking and exercise regularly.
Other risk factors for atherosclerosis were treated
medically.
Follow-up was performed by the vascular surgeon
and included assessment of symptoms, physical ex-
amination, determination of ankle brachial pressure
index (ABPI), treadmill test and CDU of the treated
lesions. Assessment was performed at approximately
1, 6 and 12 months after treatment, and with 6e12
months intervals thereafter.
Technical success was defined as a residual stenosis
of less than 50% on a post-procedural angiography or
a resting trans-stenotic systolic pressure gradient of
less than 10%. Clinical patency was defined as either
the absence of symptoms or improvement by at least
one category according to the SVS/ISCVS classifica-
tion. Hemodynamic aortic patency was defined as
an ABPI greater then 0.90, a minimal increase in
ABPI of 0.15, or normal peak systolic velocity (PSV)
in the treated lesion (PSV< 200 cm/s, PSV ratio< 2)
on CDU after the procedure.
Clinical and hemodynamic patencies of the aortic
segments treated with primary stenting were deter-
mined with Kaplan-Meier analysis using SPSS statisti-
cal software (version 9.0). Primary aortic patency was
defined as that achieved after the first stent placement
and secondary aortic patency as that achieved after all
complementary percutaneous procedures performed
during follow-up.
Results
The characteristics of the patients and treated lesions
are presented in Table 1. The majority of patients
629Results of Primary Stenting in Infrarenal Aortic StenosisFig. 1. AeD: A 54-year-old women with moderate claudication. A. Antero-posterior and B. oblique angiogram show a focal
eccentric stenosis of the distal aorta below the origin of a patent inferior mesenteric artery. C. After primary stenting with
a Smart stent antero-posterior and D. oblique angiogram show little residual aortic plaque with continued patency of the
IMA. After stent placement the systolic pressure gradient was 5 mmHg. The patient completely cured from her claudication
and the stented aorta remained patent during the 42 months of follow-up.were relatively young women who smoked and had
high lipid levels.
According to our definition, stent placement was
technically successful in 14 of 17 (82%) patients. Threepatients were considered technically unsuccessful. In
two patients post procedural angiography showed
a residual stenosis of less than 50% but there was
a trans-stenotic pressure gradient of 15%. However,Eur J Vasc Endovasc Surg Vol 32, December 2006
630 P. C. G. Simons et al.both patients were completely cured of their intermit-
tent claudication and their ABPI returned to >0.9. In
the third patient there was a residual stenosis of
more than 50% on post procedural angiography and
a 15% trans-stenotic systolic pressure gradient after
the procedure. She had no improvement of her symp-
toms and the ABPI increased by only 0.08 in both legs
immediately after stent placement. However, at one
month follow-up CDU showed a patent aortic stent
(maximum PSV of 175 cm/s). In addition, the pa-
tients’ iliac arteries were both slightly stenosed and
her right superficial femoral artery (SFA) was oc-
cluded. Because of severe comorbidity the occluded
SFA was treated conservatively.
Major complications occurred in two patients. In
one patient post procedural angiography showed
a dissection of the common femoral artery at the
puncture site which was treated surgically with end-
arterectomy and Dacron patchplasty. The other pa-
tient presented with acute symptoms of her left leg
12 days after she was treated with an aortic stent
and bilateral iliac stents. The stents in the left and
right common iliac arteries were totally and subtotally
occluded, respectively. The patient was successfully
treated with intra-arterial thrombolysis with uroki-
nase and subsequent PTA of the residual stenoses in
the iliac stents. There were no minor complications
in our series.
During amean follow-up time of 27months (median
18 months, range 1e86 months) symptoms recurred in
four patients. Two of four patients had a restenosis of
the aortic stent at 3 and 3.8 years, respectively. One of
these patients was successfully treated with in-stent
PTA. In the other patient further stent placement was
necessary because of residual stenosis accompanied
by a pressure gradient of 10% after PTA. In one patient
recurrent symptoms were due to occlusion of the
superficial femoral artery three months after aortic
stent placement, which was treated surgically with a
reversed saphenous vein femoro-popliteal bypass.
This patient died three months later because of sudden
death. The fourth patient, in whom the procedure was
complicated by occlusion of the iliac stents 12 days
following treatment as described above, developed re-
current symptoms due to restenoses in both iliac stents
at 1 year. She has been scheduled for an aortobifemoral
bypass operation. These last two patients had deterio-
ration of ABPI of more than 0.15 but their aortic stent
was patent at CDU.
Primary aortic patency was 83% at 3 years and 55%
at the end of follow-up (86 months) (Fig. 2). Secondary
aortic patency was 100% at the end of follow-up. The
primary clinical patency was 94%, 88%, 81%, 68% and
45% at 1, 3, 12, 36 and 44 months, respectively (Fig. 3).Eur J Vasc Endovasc Surg Vol 32, December 2006In three of five patients who deteriorated arterial
stenosis or occlusion distal to the stented aorta was
responsible.
Discussion
PTA of abdominal aortic stenosis is less invasive and
less expensive than surgical therapy. Because of en-
couraging primary (>70%) and secondary (>85%)
patency rates, PTA has been advocated as the initial
treatment modality for distal aortic stenosis.6e16 Stent
implantation after failed PTA may increase the suc-
cess rate.17e26 Theoretical disadvantages of PTA alone
may be distal embolization, especially in complex
stenoses such as eccentric, irregular, ulcerated or
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Fig. 2. Primary aortic patency in 17 patients who underwent
primary stenting for aortic stenosis.
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Fig. 3. Primary clinical patency.
631Results of Primary Stenting in Infrarenal Aortic Stenosiscalcified lesions, as well as the risk of aortic rupture
during dilation because of the larger diameter of the
abdominal aorta (according to the law of Laplace).34
For these reasons primary stenting may be preferable
to balloon angioplasty.
To our knowledge there are only 6 studies in the lit-
erature reporting primary stenting of focal distal aor-
tic stenoses27e32 (Table 2). All series including the
present study have small patient numbers due to
the rare occurrence of the disease. The patient popula-
tion differs from the usual atherosclerotic cohort. The
majority of patients are relatively young females who
are heavy smokers and have elevated lipid levels but
have less extensive atherosclerotic disease than pa-
tients who present with iliofemoral or more distal dis-
ease. This explains why the mean pre-treatment ABI is
relatively high. Furthermore, aortic stenosis is often
associated with the hypoplastic aortoiliac syndrome.35
Early onset of symptoms in these patients is explained
by the presence of small diameter vessels with ob-
struction of the lumen by atherosclerotic plaques.
Reported technical success of primary aortic stent-
ing ranges from 87% to 100%, depending on the defi-
nition by the author. We had a slightly lower technical
success rate of 82%. However, in the three patients
with an unsuccessful technical result of stent place-
ment according to our definition (i.e. trans-stenotic
systolic pressure gradient> 10%), the aortic stent
was patent at CDU and two of three patients were
completely cured of their intermittent claudication.
Diethrich et al.20 considered complete resolution of
the pressure gradient as the only end point for suc-
cessful angioplasty. However, it should be stressed
that the importance of the residual pressure gradient
that may be tolerated after stent placement of the in-
frarenal aorta is unknown, and many patients are re-
ported to be free of symptoms after aortic PTA or
stenting despite residual pressure gradients.7,32
The mid- and long-term aortic patency rates in the
literature range from 83% to 100% and can be consid-
ered as excellent. Furthermore, secondary patency
was 100% in all studies. These numbers seem consis-
tent although conclusions still may be difficult to
draw because of the relatively small number of pa-
tients, differences in patient selection and follow-up
periods. The first three studies in Table 2 for example
have not determined patency rates with the Kaplan-
Meier analyses, i.e. follow-up period are not taken
into account. Primary patency rates in these studies
are generally higher than in the last three studies,
but their follow-up periods are shorter.
The clinical success rate in our study of 68% at 3
years was lower than the stent patency which is ex-
plained by stenosis or occlusions not related to the Ta
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632 P. C. G. Simons et al.aortic segment in three of five patients with clinical
deterioration at follow-up. Other studies also report
recurrence of symptoms to be higher than recurrence
of local aortic stenosis for the same reasons (Table 2).
Two major complications occurred in our study.
Dissection of the puncture site was successfully treated
with endarterectomy and a Dacron patch. In the other
patient the iliac stents trombosed but the aortic stent
remained patent. Thus, these complications were indi-
rectly related to the aortic stent placement. Complica-
tions such as aortic rupture and distal embolization
with limb loss did not occur in our study or in the other
studies regarding primary stenting.
In our study there was one patient with a local oc-
clusion of the distal aorta. At the time of diagnosis
a severe stenosis was observed on CDU, but angiogra-
phy immediately before stenting showed an occluded
aorta. The occlusion was easily transversed with
a guide wire and the stent was successfully deployed.
Reports on treating aortic occlusions with endovascu-
lar techniques are limited and its role remains to be
defined.29,36
In summary, primary stent placement in infrarenal
aortic stenosis is a safe andminimal invasive treatment
with promising long-term patency. Although there are
no randomised trials that compare surgery, PTA and
primary stent placement, we believe that the good
results in our study and that in other series confirm
that endovascular treatment of local distal aortic steno-
ses should be considered the first line treatment and
that primary stenting should be the treatment of choice
in a properly selected patient population.
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